{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T18:07:00Z","timestamp":1789063620333,"version":"build-2803163510"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,17]],"date-time":"2022-09-17T00:00:00Z","timestamp":1663372800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,17]],"date-time":"2022-09-17T00:00:00Z","timestamp":1663372800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>A group of genetically altered cells that have not transformed into a clinical or histologically identifiable state of malignancy but contains a higher risk of transforming into one is known as the field of cancerization. Numerous molecules are being investigated for their significance in the development of this phenomenon. One such protein of this family is Kaiso also known as ZBTB33 (Zinc Finger and BTB Domain containing 33). This protein belongs to the POZ-ZF family of transcription factors and may have functional tasks similar to its other siblings such as the growth and development of vertebrates and the pathogenesis of neoplastic diseases. Nevertheless, its role in the pathogenesis, progression, epithelial mesenchyal transition and field cancerization in case of oral cancer still needs exploration. Hence, this study was designed to explore the expressional differences between the mucosa of controls and those diagnosed with oral squamous cell carcinoma (OSCC).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Soft tissue samples were obtained from the main tumor, tumor periphery and opposite buccal mucosa of 50 oral cancer patients, whereas normal mucosa was taken from 50 volunteers undergoing elective tooth removal. The acquired samples were subjected to Immunohistochemical exploration for expression of Kaiso and E-Cadherin. The expression was measured using Image-J IHC profiler and summed as Optical density. The Optical density values were then subjected to statistical analysis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Results revealed a significant differential expression of Kaiso between the mucosal tissues taken from oral cancer patients and controls (<jats:italic>p<\/jats:italic>-value:\u2009&lt;\u20090.0001), showing almost 50% down-regulation of Kaiso in all three tissue samples taken from oral cancer patients as compared to normal mucosa.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Kaiso has a significant difference of expression in the mucosa of oral cancer patients as compared to the mucosa of normal patients, making it a probable contributor to disease pathogenesis and field cancerization.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12885-022-10014-7","type":"journal-article","created":{"date-parts":[[2022,9,17]],"date-time":"2022-09-17T09:03:42Z","timestamp":1663405422000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Expressional variations of Kaiso: an association with pathological characteristics and field cancerization of OSCC"],"prefix":"10.1186","volume":"22","author":[{"given":"Shaheen","family":"Ahmed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeed","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Asif","family":"Qureshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uzma","family":"Bukhari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehak","family":"Anis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Nouman","family":"Mughal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,17]]},"reference":[{"issue":"8","key":"10014_CR1","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1016\/j.ijom.2018.01.020","volume":"47","author":"N Eljabo","year":"2018","unstructured":"Eljabo N, Nikolic N, Carkic J, Jelovac D, Lazarevic M, Tanic N, et al. Genetic and epigenetic alterations in the tumour, tumour margins, and normal buccal mucosa of patients with oral cancer. Int J Oral Maxillofac Surg. 2018;47(8):976\u201382.","journal-title":"Int J Oral Maxillofac Surg"},{"issue":"1","key":"10014_CR2","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/nrc.2017.102","volume":"18","author":"K Curtius","year":"2018","unstructured":"Curtius K, Wright NA, Graham TA. An evolutionary perspective on field cancerization. Nat Rev Cancer. 2018;18(1):19\u201332.","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"10014_CR3","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1002\/1097-0142(195309)6:5<963::AID-CNCR2820060515>3.0.CO;2-Q","volume":"6","author":"DP Slaughter","year":"1953","unstructured":"Slaughter DP, Southwick HW, Smejkal W. \u201cField cancerization\u201d in oral stratified squamous epithelium. Clinical implications of multicentric origin. Cancer. 1953;6(5):963\u20138.","journal-title":"Cancer"},{"issue":"1","key":"10014_CR4","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/BF02890059","volume":"58","author":"FX Bosch","year":"1989","unstructured":"Bosch FX, Ouhayoun J-P, Bader BL, Collin C, Grund C, Lee I, et al. Extensive changes in cytokeratin expression patterns in pathologically affected human gingiva. Virchows Archiv B. 1989;58(1):59.","journal-title":"Virchows Archiv B"},{"issue":"3","key":"10014_CR5","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1002\/(SICI)1096-9896(199603)178:3<284::AID-PATH470>3.0.CO;2-9","volume":"178","author":"V Bongers","year":"1996","unstructured":"Bongers V, Snow GB, De Vries N, Braakhuis BJ. Potential early markers of carcinogenesis in the mucosa of the head and neck using exfoliative cytology. J Pathol. 1996;178(3):284\u20139.","journal-title":"J Pathol"},{"issue":"4","key":"10014_CR6","first-page":"949","volume":"55","author":"J Bartkova","year":"1995","unstructured":"Bartkova J, Lukas J, M\u00fcller H, Strauss M, Gusterson B, Bartek J. Abnormal patterns of D-type cyclin expression and G1 regulation in human head and neck cancer. Can Res. 1995;55(4):949\u201356.","journal-title":"Can Res"},{"issue":"6","key":"10014_CR7","first-page":"1373","volume":"19","author":"MM Bloching","year":"2008","unstructured":"Bloching MM, Soulsby H, Naumann A, Aust W, Merkel D, Braun T, et al. Tumor risk assessment by means of immunocytochemical detection of early pre-malignant changes in buccal smears. Oncol Rep. 2008;19(6):1373\u20139.","journal-title":"Oncol Rep"},{"issue":"12","key":"10014_CR8","first-page":"3153","volume":"54","author":"DM Shin","year":"1994","unstructured":"Shin DM, Ro JY, Hong WK, Hittelman WN. Dysregulation of epidermal growth factor receptor expression in premalignant lesions during head and neck tumorigenesis. Can Res. 1994;54(12):3153\u20139.","journal-title":"Can Res"},{"issue":"1","key":"10014_CR9","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/j.1601-0825.1998.tb00247.x","volume":"4","author":"M Van Oijen","year":"1998","unstructured":"Van Oijen M, Rijksen G, Broek Ft, Slootweg PJ. Increased expression of epidermal growth factor receptor in normal epithelium adjacent to head and neck carcinomas independent of tobacco and alcohol abuse. Oral Dis. 1998;4(1):4\u20138.","journal-title":"Oral Dis"},{"issue":"15","key":"10014_CR10","first-page":"3579","volume":"53","author":"JR Grandis","year":"1993","unstructured":"Grandis JR, Tweardy DJ. Elevated levels of transforming growth factor \u03b1 and epidermal growth factor receptor messenger RNA are early markers of carcinogenesis in head and neck cancer. Can Res. 1993;53(15):3579\u201384.","journal-title":"Can Res"},{"issue":"4","key":"10014_CR11","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/S1368-8375(98)80011-0","volume":"34","author":"MG van Oijen","year":"1998","unstructured":"van Oijen MG, Gilsing MMA, Rijksen G, Hordijk GJ, Slootweg PJ. Increased number of proliferating cells in oral epithelium from smokers and ex-smokers. Oral Oncol. 1998;34(4):297\u2013303.","journal-title":"Oral Oncol"},{"issue":"6","key":"10014_CR12","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/S0964-1955(97)00033-X","volume":"33","author":"MA Birchall","year":"1997","unstructured":"Birchall MA, Schock E, Harmon BV, Gobe G. Apoptosis, mitosis, PCNA and bcl-2 in normal, leukoplakic and malignant epithelia of the human oral cavity: prospective, in vivo study. Oral Oncol. 1997;33(6):419\u201325.","journal-title":"Oral Oncol"},{"issue":"1","key":"10014_CR13","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.oraloncology.2004.06.008","volume":"41","author":"R El-Gazzar","year":"2005","unstructured":"El-Gazzar R, Macluskey M, Ogden GR. Evidence for a field change effect based on angiogenesis in the oral mucosa? A brief report. Oral Oncol. 2005;41(1):25\u201330.","journal-title":"Oral Oncol"},{"issue":"4","key":"10014_CR14","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1002\/(SICI)1096-9896(199804)184:4<360::AID-PATH1263>3.0.CO;2-H","volume":"184","author":"IB Cruz","year":"1998","unstructured":"Cruz IB, Snijders PJ, Meijer CJ, Braakhuis BJ, Snow GB, Walboomers JM, et al. p53 expression above the basal cell layer in oral mucosa is an early event of malignant transformation and has predictive value for developing oral squamous cell carcinoma. J Pathol. 1998;184(4):360\u20138.","journal-title":"J Pathol"},{"issue":"2","key":"10014_CR15","doi-asserted-by":"publisher","first-page":"334","DOI":"10.3109\/00016489509139324","volume":"115","author":"JP Lavieille","year":"1995","unstructured":"Lavieille JP, Brambilla E, Riva-Lavieille C, Reyt E, Charachon R, Brambilla C. Immunohistochemical detection of p53 protein in preneoplastic lesions and squamous cell carcinoma of the head and neck. Acta Otolaryngol. 1995;115(2):334\u20139.","journal-title":"Acta Otolaryngol"},{"issue":"7","key":"10014_CR16","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1002\/1097-0142(19950401)75:7<1657::AID-CNCR2820750716>3.0.CO;2-G","volume":"75","author":"Y Nakanishi","year":"1995","unstructured":"Nakanishi Y, Noguchi M, Mukai K, Matsuno Y, Hirohashi S, Saikawa M, et al. p53 expression in multicentric squamous cell carcinoma and surrounding squamous epithelium of the upper aerodigestive tract. Immunohistochemical analysis of 95 lesions. Cancer. 1995;75(7):1657\u201362.","journal-title":"Cancer"},{"issue":"18","key":"10014_CR17","first-page":"4189","volume":"53","author":"M Nees","year":"1993","unstructured":"Nees M, Homann N, Discher H, Andl T, Enders C, Herold-Mende C, et al. Expression of mutated p53 occurs in tumor-distant epithelia of head and neck cancer patients: a possible molecular basis for the development of multiple tumors. Can Res. 1993;53(18):4189\u201396.","journal-title":"Can Res"},{"issue":"4","key":"10014_CR18","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1002\/(SICI)1096-9896(199903)187:4<469::AID-PATH262>3.0.CO;2-3","volume":"187","author":"MG van Oijen","year":"1999","unstructured":"van Oijen MG, van de Craats JG, Slootweg PJ. p53 overexpression in oral mucosa in relation to smoking. J Pathol. 1999;187(4):469\u201374.","journal-title":"J Pathol"},{"issue":"2","key":"10014_CR19","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/sj.onc.1200812","volume":"14","author":"F Waridel","year":"1997","unstructured":"Waridel F, Estreicher A, Bron L, Flaman JM, Fontolliet C, Monnier P, et al. Field cancerisation and polyclonal p53 mutation in the upper aero-digestive tract. Oncogene. 1997;14(2):163\u20139.","journal-title":"Oncogene"},{"issue":"12","key":"10014_CR20","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1038\/nrc1752","volume":"5","author":"FM Van Roy","year":"2005","unstructured":"Van Roy FM, McCrea PD. A role for Kaiso\u2013p120ctn complexes in cancer? Nat Rev Cancer. 2005;5(12):956\u201364.","journal-title":"Nat Rev Cancer"},{"issue":"11","key":"10014_CR21","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.tcb.2006.09.003","volume":"16","author":"KF Kelly","year":"2006","unstructured":"Kelly KF, Daniel JM. POZ for effect\u2013POZ-ZF transcription factors in cancer and development. Trends Cell Biol. 2006;16(11):578\u201387.","journal-title":"Trends Cell Biol"},{"issue":"1","key":"10014_CR22","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.bbcan.2018.10.005","volume":"1871","author":"CC Pierre","year":"2019","unstructured":"Pierre CC, Hercules SM, Yates C, Daniel JM. Dancing from bottoms up\u2013roles of the POZ-ZF transcription factor Kaiso in cancer. Biochim Biophys Acta Rev Cancer. 2019;1871(1):64\u201374.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"1","key":"10014_CR23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-016-0028-x","volume":"7","author":"X Xue","year":"2017","unstructured":"Xue X, Zhang J, Lan H, Xu Y, Wang H. Kaiso protects human umbilical vein endothelial cells against apoptosis by differentially regulating the expression of B-cell CLL\/lymphoma 2 family members. Sci Rep. 2017;7(1):1\u201316.","journal-title":"Sci Rep"},{"issue":"3","key":"10014_CR24","doi-asserted-by":"publisher","first-page":"e2689","DOI":"10.1038\/cddis.2017.92","volume":"8","author":"BI Bassey-Archibong","year":"2017","unstructured":"Bassey-Archibong BI, Rayner LG, Hercules SM, Aarts CW, Dvorkin-Gheva A, Bramson JL, et al. Kaiso depletion attenuates the growth and survival of triple negative breast cancer cells. Cell Death Dis. 2017;8(3):e2689.","journal-title":"Cell Death Dis"},{"issue":"42","key":"10014_CR25","doi-asserted-by":"publisher","first-page":"15078","DOI":"10.1073\/pnas.1318780111","volume":"111","author":"D-I Koh","year":"2014","unstructured":"Koh D-I, Han D, Ryu H, Choi W-I, Jeon B-N, Kim M-K, et al. KAISO, a critical regulator of p53-mediated transcription of CDKN1A and apoptotic genes. Proc Natl Acad Sci. 2014;111(42):15078\u201383.","journal-title":"Proc Natl Acad Sci"},{"issue":"5","key":"10014_CR26","doi-asserted-by":"publisher","first-page":"e37864","DOI":"10.1371\/journal.pone.0037864","volume":"7","author":"JF Vermeulen","year":"2012","unstructured":"Vermeulen JF, van de Ven RA, Ercan C, van der Groep P, van der Wall E, Bult P, et al. Nuclear Kaiso expression is associated with high grade and triple-negative invasive breast cancer. PLoS ONE. 2012;7(5):e37864.","journal-title":"PLoS ONE"},{"key":"10014_CR27","doi-asserted-by":"crossref","unstructured":"Jones J, Wang H, Karanam B, Theodore S, Dean-Colomb WM, Welch DR, et al. Nuclear localization of Kaiso as a prognostic biomarker and promotion of EMT in infiltrating ductal breast carcinomas. Am Soc Clin Oncol. 2014.","DOI":"10.1200\/jco.2014.32.15_suppl.e22061"},{"issue":"11","key":"10014_CR28","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1007\/s10552-017-0955-2","volume":"28","author":"BI Bassey-Archibong","year":"2017","unstructured":"Bassey-Archibong BI, Hercules SM, Rayner LG, Skeete DH, Connell SPS, Brain I, et al. Kaiso is highly expressed in TNBC tissues of women of African ancestry compared to Caucasian women. Cancer Causes Control. 2017;28(11):1295\u2013304.","journal-title":"Cancer Causes Control"},{"issue":"9","key":"10014_CR29","doi-asserted-by":"publisher","first-page":"e0183883","DOI":"10.1371\/journal.pone.0183883","volume":"12","author":"JM Kwiecien","year":"2017","unstructured":"Kwiecien JM, Bassey-Archibong BI, Dabrowski W, Rayner LG, Lucas AR, Daniel JM. Loss of Kaiso expression in breast cancer cells prevents intra-vascular invasion in the lung and secondary metastasis. PLoS ONE. 2017;12(9):e0183883.","journal-title":"PLoS ONE"},{"issue":"1","key":"10014_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2407-9-178","volume":"9","author":"S-D Dai","year":"2009","unstructured":"Dai S-D, Wang Y, Miao Y, Zhao Y, Zhang Y, Jiang G-Y, et al. Cytoplasmic Kaiso is associated with poor prognosis in non-small cell lung cancer. BMC Cancer. 2009;9(1):1\u201313.","journal-title":"BMC Cancer"},{"issue":"5","key":"10014_CR31","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1016\/j.ajpath.2012.08.008","volume":"181","author":"J Jones","year":"2012","unstructured":"Jones J, Wang H, Zhou J, Hardy S, Turner T, Austin D, et al. Nuclear Kaiso indicates aggressive prostate cancers and promotes migration and invasiveness of prostate cancer cells. Am J Pathol. 2012;181(5):1836\u201346.","journal-title":"Am J Pathol"},{"issue":"5","key":"10014_CR32","doi-asserted-by":"publisher","first-page":"5677","DOI":"10.18632\/oncotarget.6801","volume":"7","author":"H Wang","year":"2016","unstructured":"Wang H, Liu W, Black S, Turner O, Daniel JM, Dean-Colomb W, et al. Kaiso, a transcriptional repressor, promotes cell migration and invasion of prostate cancer cells through regulation of miR-31 expression. Oncotarget. 2016;7(5):5677.","journal-title":"Oncotarget"},{"issue":"2","key":"10014_CR33","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.canlet.2016.06.025","volume":"380","author":"J Jones","year":"2016","unstructured":"Jones J, Mukherjee A, Karanam B, Davis M, Jaynes J, Reams RR, et al. African Americans with pancreatic ductal adenocarcinoma exhibit gender differences in Kaiso expression. Cancer Lett. 2016;380(2):513\u201322.","journal-title":"Cancer Lett"},{"issue":"1","key":"10014_CR34","doi-asserted-by":"publisher","first-page":"e12","DOI":"10.1097\/PAI.0000000000000370","volume":"25","author":"SM SeyedJafari","year":"2017","unstructured":"SeyedJafari SM, Hunger R. IHC optical density score: a new practical method for quantitative immunohistochemistry image analysis. Appl Immunohistochem Mol Morphol. 2017;25(1):e12\u20133.","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10014_CR35","unstructured":"BRODERS AC. The microscopic grading of cancer. The surgical clinics of north America. 1941;21:947\u201362."},{"issue":"4","key":"10014_CR36","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1002\/path.1711660409","volume":"166","author":"M Bryne","year":"1992","unstructured":"Bryne M, Koppang HS, Lilleng R, Kj\u00e6rheim \u00c5. Malignancy grading of the deep invasive margins of oral squamous cell carcinomas has high prognostic value. J Pathol. 1992;166(4):375\u201381.","journal-title":"J Pathol"},{"issue":"7","key":"10014_CR37","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1111\/his.13173","volume":"70","author":"M Boxberg","year":"2017","unstructured":"Boxberg M, Jesinghaus M, Dorfner C, Mogler C, Drecoll E, Warth A, et al. Tumour budding activity and cell nest size determine patient outcome in oral squamous cell carcinoma: proposal for an adjusted grading system. Histopathology. 2017;70(7):1125\u201337.","journal-title":"Histopathology"},{"issue":"4","key":"10014_CR38","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1002\/path.1242","volume":"198","author":"VM van Houten","year":"2002","unstructured":"van Houten VM, Tabor MP, van den Brekel MW, Alain Kummer J, Denkers F, Dijkstra J, et al. Mutated p53 as a molecular marker for the diagnosis of head and neck cancer. J Pathol. 2002;198(4):476\u201386.","journal-title":"J Pathol"},{"issue":"3","key":"10014_CR39","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1002\/ijc.2910640309","volume":"64","author":"AK El-Naggar","year":"1995","unstructured":"El-Naggar AK, Lai S, Luna MA, Zhou X-D, Weber RS, Goepfert H, et al. Sequential p53 mutation analysis of pre-invasive and invasive head and neck squamous carcinoma. Int J Cancer. 1995;64(3):196\u2013201.","journal-title":"Int J Cancer"},{"key":"10014_CR40","volume-title":"Over expression of p53 and p21 in normal oral mucosa adjacent to resected squamous cell carcinomas","author":"E Reda","year":"2005","unstructured":"Reda E, Reda N. Over expression of p53 and p21 in normal oral mucosa adjacent to resected squamous cell carcinomas. 2005."},{"issue":"18","key":"10014_CR41","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1038\/sj.onc.1202153","volume":"17","author":"JG Izzo","year":"1998","unstructured":"Izzo JG, Papadimitrakopoulou VA, Li XQ, Ibarguen H, Lee JS, Ro JY, et al. Dysregulated cyclin D1 expression early in head and neck tumorigenesis: in vivo evidence for an association with subsequent gene amplification. Oncogene. 1998;17(18):2313\u201322.","journal-title":"Oncogene"},{"issue":"19","key":"10014_CR42","first-page":"7264","volume":"61","author":"BH Ortiz","year":"2001","unstructured":"Ortiz BH, Ailawadi M, Colitti C, Muto MG, Deavers M, Silva EG, et al. Second primary or recurrence? Comparative patterns of p53 and K-ras mutations suggest that serous borderline ovarian tumors and subsequent serous carcinomas are unrelated tumors. Can Res. 2001;61(19):7264\u20137.","journal-title":"Can Res"},{"issue":"6","key":"10014_CR43","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/S0002-9610(96)00304-2","volume":"172","author":"R Werkmeister","year":"1996","unstructured":"Werkmeister R, Brandt B, Joos U. The erbB oncogenes as prognostic markers in oral squamous cell carcinomas. Am J Surg. 1996;172(6):681\u20133.","journal-title":"Am J Surg"},{"issue":"6","key":"10014_CR44","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1093\/carcin\/bgp212","volume":"31","author":"K Szyma\u0144ska","year":"2010","unstructured":"Szyma\u0144ska K, Levi JE, Menezes A, W\u00fcnsch-Filho V, Eluf-Neto J, Koifman S, et al. TP53 and EGFR mutations in combination with lifestyle risk factors in tumours of the upper aerodigestive tract from South America. Carcinogenesis. 2010;31(6):1054\u20139.","journal-title":"Carcinogenesis"},{"issue":"1","key":"10014_CR45","doi-asserted-by":"publisher","first-page":"22","DOI":"10.4103\/0973-029X.92968","volume":"16","author":"M Astekar","year":"2012","unstructured":"Astekar M, Joshi A, Ramesh G, Metgud R. Expression of vascular endothelial growth factor and microvessel density in oral tumorigenesis. J Oral Maxillofac Pathol. 2012;16(1):22.","journal-title":"J Oral Maxillofac Pathol"},{"issue":"5","key":"10014_CR46","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/j.tripleo.2009.06.028","volume":"108","author":"SA L\u00f3pez-Blanc","year":"2009","unstructured":"L\u00f3pez-Blanc SA, Collet AM, Gandolfo MS, Femopase F, Hern\u00e1ndez SL, Tomasi VH, et al. Nucleolar organizer regions (AgNOR) and subepithelial vascularization as field cancerization markers in oral mucosa biopsies of alcoholic and smoking patients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009;108(5):747\u201353.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10014_CR47","unstructured":"Daniel: The p120 ctn-binding partner Kaiso is a bi-modal... - Google Scholar ["},{"issue":"38","key":"10014_CR48","doi-asserted-by":"publisher","first-page":"15229","DOI":"10.1073\/pnas.1213726109","volume":"109","author":"BA Buck-Koehntop","year":"2012","unstructured":"Buck-Koehntop BA, Stanfield RL, Ekiert DC, Martinez-Yamout MA, Dyson HJ, Wilson IA, et al. Molecular basis for recognition of methylated and specific DNA sequences by the zinc finger protein Kaiso. Proc Natl Acad Sci. 2012;109(38):15229\u201334.","journal-title":"Proc Natl Acad Sci"},{"issue":"11","key":"10014_CR49","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1038\/s41418-018-0078-7","volume":"25","author":"S Zhenilo","year":"2018","unstructured":"Zhenilo S, Deyev I, Litvinova E, Zhigalova N, Kaplun D, Sokolov A, et al. DeSUMOylation switches Kaiso from activator to repressor upon hyperosmotic stress. Cell Death Differ. 2018;25(11):1938\u201351.","journal-title":"Cell Death Differ"},{"issue":"1","key":"10014_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1475-2867-12-28","volume":"12","author":"J Cofre","year":"2012","unstructured":"Cofre J, Menezes JR, Pizzatti L, Abdelhay E. Knock-down of Kaiso induces proliferation and blocks granulocytic differentiation in blast crisis of chronic myeloid leukemia. Cancer Cell Int. 2012;12(1):1\u201314.","journal-title":"Cancer Cell Int"},{"key":"10014_CR51","volume-title":"Kaiso: a novel mediator of intestinal inflammation and tumorigenesis [PhD Thesis]","author":"C Pierre","year":"2015","unstructured":"Pierre C. Kaiso: a novel mediator of intestinal inflammation and tumorigenesis [PhD Thesis]. 2015."}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-022-10014-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-022-10014-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-022-10014-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,19]],"date-time":"2022-11-19T09:04:56Z","timestamp":1668848696000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-022-10014-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,17]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["10014"],"URL":"https:\/\/doi.org\/10.1186\/s12885-022-10014-7","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,17]]},"assertion":[{"value":"4 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study has been conducted after taking endorsement from the Institutional Review Board of Dow University of Health Sciences IRB No: IRB-1319\/DUHS\/Approval\/2019. All techniques employed in the study were in agreement with the 1964 Helsinki Declaration and the standards approved by the institutional and\/or national research committee. Informed consent was obtained in writing from all the research participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The current study does not contain any images or videos related to any research participant. The consent for publication is obtained from all research participants included in the current study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"990"}}